John M. Kovarik;Marie-Claude Bastien;Goeril Karlsson;Robert Schmouder;Olivier David
发明人:
John M. Kovarik,Robert Schmouder,Marie-Claude Bastien,Olivier David,Goeril Karlsson
申请号：
US15086174
公开号：
US20160206574A1
申请日:
2016.03.31
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
